Home/Pipeline/Cardiac Arrhythmia (AFib) Program

Cardiac Arrhythmia (AFib) Program

Paroxysmal Atrial Fibrillation

Phase 2Active

Key Facts

Indication
Paroxysmal Atrial Fibrillation
Phase
Phase 2
Status
Active
Company

About Parasym Health

Parasym Health is a clinical-stage neuromodulation company with a patented wearable device designed to deliver precise bioelectric signals to the vagus nerve. Its technology, backed by over $10M in R&D and 50+ clinical studies, has demonstrated proof-of-concept in areas including cardiac arrhythmia, learning enhancement, and immune modulation. The company operates a B2B and direct-to-consumer model, partnering with over 100 elite research institutions and targeting a broad market spanning healthcare, sports performance, and defense.

View full company profile

Other Paroxysmal Atrial Fibrillation Drugs

DrugCompanyPhase
Home Cardioversion ProgramInCarda TherapeuticsPreclinical